Human chorionic gonadotrophin-beta transcripts correlate with progesterone receptor values in breast carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• The role of human chorionic gonadotropin (hCG) in cancer is not well understood.
• hCG-beta gene expression has been observed in various tumors, but its specific function in breast neoplasms remains speculative.

Purpose of the Study:

• To investigate the expression of hCG-beta mRNA in breast carcinoma, fibroadenoma, and macromastia.
• To determine the correlation between hCG-beta mRNA expression and clinicopathological features, including progesterone receptor (PgR) status and patient survival.

Main Methods:

• Quantitative reverse transcriptase-PCR was used to measure hCG-beta mRNA levels in 214 breast cancer samples, 37 fibroadenomas, and 10 macromastia tissues.
• Statistical analyses were performed to compare hCG-beta mRNA expression across different breast tissue types and to assess its relationship with PgR status and survival outcomes.

Main Results:

• hCG-beta mRNA was detected in 37.4% of breast carcinomas and 56.8% of fibroadenomas.
• Fibroadenomas exhibited higher hCG-beta mRNA copy numbers compared to breast cancers.
• No significant differences in disease-free or overall survival were associated with hCG-beta mRNA status in breast cancer patients.

Conclusions:

• The study does not support a role for hCG-beta in the malignant transformation of human breast cells.
• Findings indicate a potential involvement of hCG-beta in benign breast conditions like fibroadenoma.
• A positive correlation between hCG-beta mRNA and PgR levels suggests progestins may regulate hCG-beta expression in breast epithelial cells.